Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuhiko Nakagawa

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 17, 2020
[A Case of Small Cell Carcinoma of Esophagus in Which Long-Term Survival Was Achieved with Multimodal Treatment]Akira Mizuno, Ikue Nonogaki, Nobuhiko Nakagawa, et al.
Anticancer Research|December 1, 2022
Significance of Zinc Replacement Therapy After PancreaticoduodenectomyChie Takishita, Yuichi Nagakawa, Hiroaki Osakabe, et al.
Surgery Today|May 17, 2025
Long-term outcomes of prophylactic right-half dissection of the superior mesenteric artery nerve plexus in pancreatoduodenectomy for pancreatic ductal adenocarcinoma: five-year results from a randomized phase II trialYuki Matsui, Daisuke Hashimoto, Nobuhiko Nakagawa, et al.
Annals of Surgical Oncology|December 19, 2019
Clinical Implications of Naples Prognostic Score in Patients with Resected Pancreatic CancerNobuhiko Nakagawa, Suguru Yamada, Fuminori Sonohara, et al.
Pancreas|December 3, 2024
Phase II Randomized Controlled Trial to Evaluate the Supportive Effect of Koujin (TJ-3020) Powder in Gemcitabine and Nab-Paclitaxel-Treated Unresectable or Recurrent Pancreatic CancerTomohisa Otsu, Hideki Takami, Suguru Yamada, et al.
Annals of Surgical Oncology|May 30, 2026
High Serum IgA Identifies Poor Responders to Immune Checkpoint Inhibitors in Patients with Unresectable Esophageal Squamous Cell CarcinomaKosaku Torii, Akimitsu Iizuka, Dai Shimizu, et al.
Oncology Letters|June 4, 2021
Novel prognostic implications of YTH domain family 2 in resected hepatocellular carcinomaNobuhiko Nakagawa, Fuminori Sonohara, Katsuhito Tanaka, et al.
Anticancer Research|December 8, 2020
Novel Prognostic Implications of Methylated RNA and Demethylases in Resected HCC and Background Liver TissueNobuhiko Nakagawa, Katsuhito Tanaka, Fuminori Sonohara, et al.
Anticancer Research|March 28, 2025
Exploration of Lipid Mediators for Therapeutic Monitoring of Pancreatic Cancer PatientsNobuhiko Nakagawa, Masamichi Hayashi, Daigo Kobayashi, et al.
Anticancer Research|May 31, 2024
Prognostic Impact of <i>CDKN2A</i> Mutations Associated With Smoking and Drinking History in Japanese Digestive CancersKeizo Fujita, Masamichi Hayashi, Nobuhiko Nakagawa, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 17, 2020
[A Case of Small Cell Carcinoma of Esophagus in Which Long-Term Survival Was Achieved with Multimodal Treatment]Akira Mizuno, Ikue Nonogaki, Nobuhiko Nakagawa, et al.
Anticancer Research|December 1, 2022
Significance of Zinc Replacement Therapy After PancreaticoduodenectomyChie Takishita, Yuichi Nagakawa, Hiroaki Osakabe, et al.
Surgery Today|May 17, 2025
Long-term outcomes of prophylactic right-half dissection of the superior mesenteric artery nerve plexus in pancreatoduodenectomy for pancreatic ductal adenocarcinoma: five-year results from a randomized phase II trialYuki Matsui, Daisuke Hashimoto, Nobuhiko Nakagawa, et al.
Annals of Surgical Oncology|December 19, 2019
Clinical Implications of Naples Prognostic Score in Patients with Resected Pancreatic CancerNobuhiko Nakagawa, Suguru Yamada, Fuminori Sonohara, et al.
Pancreas|December 3, 2024
Phase II Randomized Controlled Trial to Evaluate the Supportive Effect of Koujin (TJ-3020) Powder in Gemcitabine and Nab-Paclitaxel-Treated Unresectable or Recurrent Pancreatic CancerTomohisa Otsu, Hideki Takami, Suguru Yamada, et al.
Annals of Surgical Oncology|May 30, 2026
High Serum IgA Identifies Poor Responders to Immune Checkpoint Inhibitors in Patients with Unresectable Esophageal Squamous Cell CarcinomaKosaku Torii, Akimitsu Iizuka, Dai Shimizu, et al.
Oncology Letters|June 4, 2021
Novel prognostic implications of YTH domain family 2 in resected hepatocellular carcinomaNobuhiko Nakagawa, Fuminori Sonohara, Katsuhito Tanaka, et al.
Anticancer Research|December 8, 2020
Novel Prognostic Implications of Methylated RNA and Demethylases in Resected HCC and Background Liver TissueNobuhiko Nakagawa, Katsuhito Tanaka, Fuminori Sonohara, et al.
Anticancer Research|March 28, 2025
Exploration of Lipid Mediators for Therapeutic Monitoring of Pancreatic Cancer PatientsNobuhiko Nakagawa, Masamichi Hayashi, Daigo Kobayashi, et al.
Anticancer Research|May 31, 2024
Prognostic Impact of <i>CDKN2A</i> Mutations Associated With Smoking and Drinking History in Japanese Digestive CancersKeizo Fujita, Masamichi Hayashi, Nobuhiko Nakagawa, et al.
Pageof 2